Sharon N. Conley

Tafkak, Inc. provides genome sequencing and analysis solutions. It offers tools and solutions to researchers, drug developers and clinicians determine the genetic basis of human disease and drug response. The firm provides knomeCLINIC a software suite that helps medical researchers and clinicians interpret human genomes for biological relevance; kGAP a cloud-enabled genome informatics engine that automates the process of standardizing, distilling, annotating and comparing sequence data. It also offers knomeVARIANTS, a discovery-supportive interpretation tool, which helps researchers to find causal variants and genes. The company was founded by Jorge Conde and George M. Church in 2007 and is headquartered in Waltham, MA.

Boston Heart Diagnostics Corp. provides cardiovascular disease clinical services. It specializes in diagnostic testing, personalized treatment recommendations and personalized wellness programs. The company was founded by Bela F. Asztalos and Ernst J. Schaefer in 2007 and is headquartered in Framingham, MA.

TOMA Biosciences, Inc. develops and provides DNA-based cancer testing technology. The company was founded by Hanlee Ji, Lincoln Nadauld, James M. Ford, and Calvin J. Kuo in 2011 and is headquartered in Foster City, CA.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Daum GmbH & Co. KG is a German company that specializes in textile finishing services such as embroidery, laser branding, and transfer printing. The private company was founded in 2002 and is based in Trautskirchen, Germany. The company offers full-service solutions and fast project processing with a focus on high-quality results.

Trident Labs, Inc. engages in the operation of toxicology laboratories. It offers urine and oral fluid drug testing to help medical offices monitor adherence to prescription medication and abstinence from illicit drugs. The company is headquartered in Holland, MI.

Edifice Health, Inc. is a digital health spin-out company that offers a novel metric of inflammatory health, which is augmented with personalized health interventions to improve and extend healthspan. The company is based in San Mateo, CA. The company has solid underpinnings in immunological science and AI-powered technology. Edifice Health aims to tackle chronic diseases worldwide with a consumer and market-centric orientation. The company was founded by Mark M. Davis and David Furman.